Artivion, Inc.

Artivion, Inc., a Kennesaw, Georgia-based for-profit manufacturer of cardiac and vascular surgical implants, operates as a prime contractor supplying prosthetic heart valves, saphenous vein allografts, vascular grafts, aortic conduits, and related bioimplants to the Department of Veterans Affairs and the Defense Health Agency on full-and-open competition basis, with no subcontractor footprint and no SBA set-aside designations across its federal award portfolio.

Artivion's customer concentration centers overwhelmingly on the VA's Veterans Health Administration. The top five VISNs account for 40% of awards by count and 35% of combined potential value, with VISN 21 (San Francisco Bay Area) leading at 291 awards worth $4.2 million combined potential value, followed by VISN 10 (Cleveland area) at 242 awards and $3.1 million, VISN 17 (Dallas-Houston area) at 182 awards and $2.6 million, VISN 23 (Minneapolis area) at 161 awards and $2.1 million, and VISN 15 at 42 awards and $1.5 million. The Department of Defense Defense Health Agency places occasional orders; a $22.5 thousand purchase order to Walter Reed National Military Medical Center for hardware implantation units and devices in May 2025 and an $11 thousand order for ON-X mitral mechanical valves in September 2023 exemplify that engagement. Recent representative awards include a $50.25 thousand firm fixed-price purchase order from VISN 21 in April 2026 for pulmonary valve surgical implants, a $29.8 thousand order from VISN 21 in May 2026 for prosthetic pulmonary valves including deobligation for returned items, and a $19.68 thousand order from VISN 17 in May 2026 for prosthetic devices. The company's portfolio spans 2,581 prime awards over the source window, with obligated dollars at $24.6 million against $38.8 million combined potential value.

Artivion holds three primary IDV vehicles with the VA. A Blanket Purchase Agreement with VISN 15 awarded June 10, 2024, carries a $939.6 thousand ceiling through June 9, 2029, covering prosthetic heart valves (aortic, pulmonary, and mitral), vascular grafts, saphenous vein allografts, aortic conduits, and related bioimplants under firm fixed-price consignment terms with one base year and four option years. An Indefinite Delivery Contract also with VISN 15, awarded July 1, 2025, has a $91.08 thousand ceiling through June 30, 2030, for ON-X mechanical heart valve supply. A more recent single-award Indefinite Delivery Contract with VISN 21, awarded June 1, 2026, carries a $350 thousand ceiling through November 16, 2027, for ON-X heart valves and aortic prostheses with consigned inventory at VA Palo Alto Health Care System; market research confirmed the original equipment manufacturer is the sole responsible source for these products.

Activity has declined sharply over the past five years—from 68 awards in 2022 to 78 in 2023, then down to 55 in 2024, 36 in 2025, and only 12 through June 2026. Seven awards worth $270 thousand combined potential value reach ultimate completion within the next twenty-four months, creating recompete exposure. The NAICS footprint is dominated by Surgical Appliance and Supplies Manufacturing (799 awards), Surgical and Medical Instrument Manufacturing (729 awards), and Blood and Organ Banks (280 awards). PSC coding is nearly monolithic: 2,418 of 2,581 awards fall under Medical and Surgical Instruments, Equipment, and Supplies.

Artivion owns two named subsidiaries—On-X Life Technologies Inc. and Cardiogenesis Corporation—both for-profit manufacturers of goods. On-X carries the brand identity across multiple awards, with ON-X mechanical heart valves and ON-X aortic prostheses appearing as distinct line items in VA contracts. Artivion manufactures and delivers all identified products directly without subcontractor involvement, maintaining vertical integration across its cardiac surgical implant supply chain. The company has maintained a consistent federal contracting relationship with the VA since at least 1989 according to the source data's earliest award date, positioning it as an established supplier of life-critical implantable devices to the veteran healthcare system.